Mechanistically, GLP-1 receptor agonists may exert vascular protective effects by suppressing inflammation, limiting oxidative stress, and modulating key enzymes involved in extracellular matrix remodeling ( Matrix metalloproteinases, particularly MMP-9, together with their endogenous inhibitors (TIMPs), play central roles in extracellular matrix turnover and structural vascular remodeling ( The reduction in CRP, a recognized marker of aortic stiffness, medial degeneration, and systemic inflammation, further supports the anti-inflammatory profile associated with GLP-1RA therapy
Some studies have suggested that GLP-1 analogues may have a positive impact on bone health and may increase bone density
Experiments were repeated at least three times and error bars represent s.e.m
But if it were that great, wouldnt organizations like the American Diabetes Association be loudly endorsing GLP-1 microdosing
GLP1s in higher amounts also act on portions of the brain that suppress appetite and signal satiety (feeling full)
This is the one that quietly disqualifies most programs